Short Interest in Covalon Technologies Ltd. (OTCMKTS:CVALF) Declines By 52.7%

Covalon Technologies Ltd. (OTCMKTS:CVALF) was the target of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 2,600 shares, a decrease of 52.7% from the November 15th total of 5,500 shares. Based on an average trading volume of 60,700 shares, the short-interest ratio is presently 0.0 days.

Covalon Technologies Stock Down 4.0 %

Shares of OTCMKTS:CVALF traded down $0.10 during trading on Thursday, reaching $2.37. 3,900 shares of the company’s stock traded hands, compared to its average volume of 16,572. Covalon Technologies has a fifty-two week low of $0.73 and a fifty-two week high of $3.08. The company has a 50-day simple moving average of $2.52 and a 200-day simple moving average of $2.07. The firm has a market cap of $64.93 million, a PE ratio of -82.33 and a beta of -0.31.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.